Evidence map›Paper›PMID 36985917›Full record

ArticleNanomaterials (Basel, Switzerland)2023

Preparation and Characterization of PVDF-TiO

Rianyza Gayatri, Ahmad Noor Syimir Fizal, Erna Yuliwati, Md Sohrab Hossain, Juhana Jaafar, Muzafar Zulkifli, Wirach Taweepreda, Ahmad Naim Ahmad Yahaya

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rianyza GayatriInstitute of Chemical and Bioengineering Technology, Universiti Kuala Lumpur Malaysian, Alor Gajah 78000, Melaka, Malaysia.ORCID 0000-0002-6429-8542
Ahmad Noor Syimir FizalInstitute of Chemical and Bioengineering Technology, Universiti Kuala Lumpur Malaysian, Alor Gajah 78000, Melaka, Malaysia.ORCID 0000-0002-4560-4647
Erna YuliwatiProgram Study of Chemical Engineering, Faculty of Engineering, Universitas Muhammadiyah Palembang, Jalan A. Yani 13 Ulu Kota, Palembang 30263, Indonesia.
Md Sohrab HossainHICoE-Centre for Biofuel and Biochemical Research, Institute of Self-Sustainable Building, Department of Fundamental and Applied Sciences, Faculty of Science and Information Technology, Universiti Teknologi PETRONAS, Seri Iskandar 32610, Perak Darul Ridzuan, Malaysia.ORCID 0000-0002-6873-2588
Juhana JaafarAdvanced Membrane Technology Research Centre (AMTEC), Faculty of Chemical and Energy Engineering, Universiti Teknologi Malaysia, Skudai 81310, Johor, Malaysia.
Muzafar ZulkifliInstitute of Chemical and Bioengineering Technology, Universiti Kuala Lumpur Malaysian, Alor Gajah 78000, Melaka, Malaysia.ORCID 0000-0002-1423-1075
Wirach TaweepredaPolymer Science Program, Division of Physical Science, Faculty of Science, Prince of Songkla University, Hat-Yai 90110, Songkhla, Thailand.
Ahmad Naim Ahmad YahayaInstitute of Chemical and Bioengineering Technology, Universiti Kuala Lumpur Malaysian, Alor Gajah 78000, Melaka, Malaysia.ORCID 0000-0001-9784-4901

Funding

University of Kuala Lumpur UniKL/CoRI/UER20009
6 · The paper itself

Abstract

Polymeric membranes offer straightforward modification methods that make industry scaling affordable and easy; however, these materials are hydrophobic, prone to fouling, and vulnerable to extreme operating conditions. Various attempts were made in this study to fix the challenges in using polymeric membranes and create mixed-matrix membrane (MMMs) with improved properties and hydrophilicity by adding titanium dioxide (TiO

Indexed as

BSA rejectionhydrophilic modificationmixed-matrix membranesPEGphase inversionPVDFPVPTiO2ultrafiltration

Identifiers

PMID36985917
PMCPMC10057082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.